Bleeding and pneumonia in intensive care unit patients given proton pump inhibitor or histamine-2 receptor antagonist for prevention of stress ulcer: A Meta analysis

Chinese Critical Care Medicine

Volumn 22, Issue 4, 2010, Pages 221-225

  Zhou, Jun Feng ^a   Wan, Xian Yao ^a   Huang, Wei ^a   Han, Li Li ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Bleeding; Histamine 2 receptor antagonist; Meta analysis; Nosocomial; Pneumonia; Proton pump inhibitor; Stress ulcer

Indexed keywords

CIMETIDINE; ESOMEPRAZOLE; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RABEPRAZOLE; RANITIDINE;

ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; HOSPITAL INFECTION; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; META ANALYSIS; MORTALITY; PEPTIC ULCER BLEEDING; PNEUMONIA; PROPHYLAXIS; STRESS ULCER; SYSTEMATIC REVIEW;

ANTI-ULCER AGENTS; HISTAMINE H2 ANTAGONISTS; HUMANS; INTENSIVE CARE UNITS; PEPTIC ULCER; PEPTIC ULCER HEMORRHAGE; PROTON PUMP INHIBITORS;

EID: 77953918739     PISSN: 10030603     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.1003-0603.2010.04.009     Document Type: Article

References (25)

1. Stollman N, Metz DC. Pathophysiology and prophylaxis of stress ulcer in intensive care unit patients. J Crit Care, 2005, 20: 35-45. (Pubitemid 40602222)
2. Lucas CE, Sugawa C, Riddle J, et al. Natural history and surgical dilemma of "stress" gastric bleeding. Arch Surg, 1971, 102: 266-273.
3. Robertson MS, Cade JF, Clancy RL. Helicobacter pylori infection in intensive care: increased prevalence and a new nosocomial infection. Crit Care Med, 1999, 27: 1276-1280.
4. Cook DJ, Griffith LE, Walter SD, et al. The attributable mortality and length of intensive care unit stay of clinically important gastrointestinal bleeding in critically ill patients. Crit Care, 2001, 5: 368-375.
5. Prod'hom G, Leuenberger P, Koerfer J, et al. Nosocomial pneumonia in mechanically ventilated patients receiving antacid, ranitidine, or sucralfate as prophylaxis for stress ulcer, a randomized controlled trial. Ann Intern Med, 1994, 120: 653-662.
6. Cook DJ, Reeve BK, Guyatt GH, et al. Stress ulcer prophylaxis in critically ill patients, resolving discordant Meta-analyses. JAMA, 1996, 275: 308-314.
7. Messori A, Trippoli S, Vaiani M, et al. Bleeding and pneumonia in intensive care patients given ranitidine and sucralfate for prevention of stress ulcer, Meta-analysis of randomized controlled trials. BMJ, 2000, 321: 1103-1106.
8. Levy MJ, Seelig CB, Robinson NJ, et al. Comparison of omeprazole and ranitidine for stress ulcer prophylaxis. Dig Dis Sci, 1997, 42: 1255-1259. (Pubitemid 27343453)
9. Kantorova I, Svoboda P, Scheer P, et al. Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial. Hepatogastroenterology, 2004, 51: 757-761. (Pubitemid 38590958)
10. Conrad SA, Gabrielli A, Margolis B, et al. Randomized, double-blind comparison of immediate-release omeprazole oral suspension versus intravenous cimetidine for the prevention of upper gastrointestinal bleeding in critically ill patients. Crit Care Med, 2005, 33: 760-765. (Pubitemid 40504385)
11. Somberg L, Morris J Jr, Fantus R, et al. Intermittent intravenous pantoprazole and continuous cimetidine infusion: effect on gastric pH control in critically ill patients at risk of developing stress-related mucosal disease. J Trauma, 2008, 64: 1202-1210.
12. Ritchie WP Jr. Acute gastric mucosal damage induced by bile salts, acid, and ischemia. Gastroenterology 1975, 68: 699-707.
13. Kivilaakso E, Silen W. Pathogenesis of experimental gastric-mucosal injury. N Engl J Med, 1979, 301: 364-369. (Pubitemid 10242791)
14. Stollman N, Metz DC. Pathophysiology and prophylaxis of stress ulcer in intensive care unit patients. J Crit Care, 2005, 20: 35-45. (Pubitemid 40602222)
15. Priebe HJ, Skillman JJ, Bushnell LS, et al. Antacid versus cimetidine in preventing acute gastrointestinal bleeding, a randomized trial in 75 critically ill patients. N Engl J Med, 1980, 302: 426-430.
16. Tryba M, Cook D. Current guidelines on stress ulcer prophylaxis. Drugs, 1997, 54: 581-596. (Pubitemid 27464156)
17. Shuman RB, Schuster DP, Zuckerman GR. Prophylactic therapy for stress ulcer bleeding: a reappraisal. Ann Intern Med, 1987, 106: 562-567. (Pubitemid 17095045)
18. Phillips JO, Metzler MH, Palmieri MT, et al. A prospective study of simplified omeprazole suspension for the prophylaxis of stress-related mucosal damage. Crit Care Med, 1996, 24, 1793-1800.
19. Lasky MR, Metzler MH, Phillips JO. A prospective study of omeprazole suspension to prevent clinically significant gastrointestinal bleeding from stress ulcers in mechanically ventilated trauma patients. J Trauma, 1998, 44: 527-533.
20. Apte NM, Karnad DR, Medhekar TP, et al. Gastric colonization and pneumonia in intubated critically ill patients receiving stress ulcer prophylaxis: a randomized, controlled trial. Crit Care Med, 1992, 20: 590-593.
21. du Moulin GC, Peterson DG, Hedley-Whyte J, et al. Aspiration of gastric bacteria in antacid-treated patients: a frequent cause of postoperative colonisation of the airway. Lancet, 1982, 1: 242-245.
22. Craven DE, Kunches LM, Kilinsky V, et al. Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation. Am Rev Respir Dis, 1986, 133: 792-796.
23. Cook D, Guyatt G, Marshall J, et al. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. N Engl J Med, 1998, 338: 791-797. (Pubitemid 28135985)
24. Beaulieu M, Williamson D, Sirois C, et al. Do proton-pump inhibitors increase the risk for nosocomial pneumonia in a medical intensive care unit? J Crit Care, 2008, 23: 513-518.
25. Yildizdas D, Yapicioglu H, Yilmaz HL. Occurrence of ventilator-associated pneumonia in mechanically ventilated pediatric intensive care patients during stress ulcer prophylaxis with sucralfate, ranitidine, and omeprazole. J Crit Care, 2002, 17: 240-245. (Pubitemid 35447399)